Hartmann Arndt, Junker Kerstin, Dietmaier Wolfgang, Schröder Sören, Lopez Diego, Hofstädter Ferdinand, Blaszyk Hagen
Institute of Pathology, University of Regensburg, D-93042, Germany.
Hum Pathol. 2006 Jan;37(1):117-20. doi: 10.1016/j.humpath.2005.09.013. Epub 2005 Nov 28.
Nephrogenic metaplasia or nephrogenic adenoma of the urinary tract may present a diagnostic challenge in surgical pathology practice. Previous case reports suggest the possibility of nephrogenic metaplasia progressing to clear cell adenocarcinoma, but a malignant potential of nephrogenic metaplasia is generally not acknowledged. A case of a 70-year-old female patient with multiple recurrences of nephrogenic metaplasia of the urinary bladder and subsequent development of clear cell adenocarcinoma is described. Immunohistochemical studies help to differentiate the 2 entities. Results of molecular studies, particularly comparative genomic hybridization analysis, suggest clonal evolution of nephrogenic metaplasia to clear cell adenocarcinoma in this case.
尿路的肾源性化生或肾源性腺瘤在外科病理学实践中可能带来诊断挑战。既往病例报告提示肾源性化生有进展为透明细胞腺癌的可能,但肾源性化生的恶性潜能通常未得到认可。本文描述了一例70岁女性患者,其膀胱肾源性化生多次复发,随后发生透明细胞腺癌。免疫组织化学研究有助于区分这两种病变。分子研究结果,尤其是比较基因组杂交分析结果,提示该病例中肾源性化生向透明细胞腺癌的克隆性演变。